missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ Human IL-17 ELISpot Kit

Product Code. 18772234
Click to view available options
Cross Reactivity:
Human
Human, Primates
Quantity:
1 x 96-well Plate
6 x 96-well Plates
Unit Size:
1 set
This item is not returnable. View return policy

Product Code. 18772234

Brand: R&D Systems™ EL317

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

highly sensitive, microplate-based assays for the detection of cytokine secreting cells

This kit also recognizes primate IL-17
TRUSTED_SUSTAINABILITY

Specifications

Cross Reactivity Human, Primates
Includes Human/Primate IL-17/IL-17A Microplate, Biotinylated Detection Antibody, Streptavidin conjugated to Alkaline Phosphatase, Dilution Buffers, Wash Buffer Concentrate, BCIP/NBT Chromogen, Human/Primate IL-17/IL-17A Positive Control
Quantity 1 x 96-well Plate
Sample Type Whole Cells
Synonym CTLA8, CTLA-8, CTLA8cytotoxic T-lymphocyte-associated serine esterase 8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL17A, IL-17A, IL-17Acytotoxic T-lymphocyte-associated protein 8, IL-17CTLA-8, IL17interleukin-17A, interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8), interleukin 17A
Content And Storage Store the unopened product at 2°C to 8°C. Do not use past expiration date.
For Use With (Application) Quantitative determination of the frequency of cells releasing human IL-17
Product Type Human IL-17 ELISpot Kit
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.